PATRIOT Trial: Randomized phase II study of prostate stereotactic body radiotherapy comparing 11 versus 29 days overall treatment time

被引：6
|
作者：
Quon, Harvey Charles
Ong, Aldrich
Cheung, Patrick
Chu, William
Chung, Hans T.
Vesprini, Danny
Chowdhury, Amit
Panjwani, Dilip
Pang, Geordi
Korol, Renee
Davidson, Melanie
Ravi, Ananth
McCurdy, Boyd
Zhang, Liying
Bucher, Oliver
Mamedov, Alexandre
Deabreu, Andrea
Lylyk, Elizabeth
Loblaw, Andrew
机构：
[1] CancerCare Manitoba, Winnipeg, MB, Canada
[2] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON M4N 3M5, Canada
[3] BC Canc Agcy, Abbotsford, BC, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 07期
关键词：
D O I：
10.1200/jco.2015.33.7_suppl.6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6
引用
收藏
页数：1
相关论文
共 50 条
  • [11] A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer
    Kawakami, S.
    Tsumura, H.
    Satoh, T.
    Tabata, K.
    Sekiguchi, A.
    Kainuma, T.
    Nakano, M.
    Iwamura, M.
    Ishiyama, H.
    RADIATION ONCOLOGY, 2022, 17 (01)
  • [12] A randomized phase II/III study comparing stereotactic body radiotherapy (SBRT) versus conventional palliative radiotherapy (CRT) for patients with spinal metastases (NCT02512965).
    Sahgal, Arjun
    Myrehaug, Sten
    Dennis, Kristopher
    Liu, Mitchell
    Chow, Edward
    Wong, Rebecca
    Butler, James B.
    Greenspoon, Jeffrey Noah
    Fehlings, Michael G.
    Maralani, Pejman
    Masucci, Laura
    Lee, Young
    Brundage, Michael Donald
    Liu, Stanley K.
    Ding, Keyue
    Hum, Maaike
    Parulekar, Wendy R.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [13] The stereotactic prostate radiotherapy (SPORT) trial: A randomized feasibility study comparing prostate SABR to prostate and pelvic nodal SABR.
    Fairmichael, Ciaran
    Redmond, Kelly M.
    Osman, Sarah O.
    Lyons, Ciara A.
    Mitchell, Darren M.
    O'Sullivan, Joe M.
    Cole, Aidan J.
    Giacometti, Valentina
    McGarry, Conor K.
    Hounsell, Alan R.
    Irvine, Denise M.
    Lundy, Gavin S.
    Jain, Suneil
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [14] STEREOTACTIC BODY RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER: INTERIM RESULTS OF A PROSPECTIVE PHASE II CLINICAL TRIAL
    King, Christopher R.
    Brooks, James D.
    Gill, Harcharan
    Pawlicki, Todd
    Cotrutz, Cristian
    Presti, Joseph C., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (04): : 1043 - 1048
  • [15] A Phase II Trial of Stereotactic Body Radiotherapy Using 4 Fractions for Patients With Localized Prostate Cancer
    Kawakami, S.
    Hayakawa, T.
    Kainuma, T.
    Tsumura, H.
    Satoh, T.
    Tabata, K. I.
    Iwamura, M.
    Hayakawa, K.
    Ishiyama, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E275 - E275
  • [16] A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)
    Wolfe, Sydney
    Diven, Marshall A.
    Marciscano, Ariel E.
    Zhou, Xi Kathy
    Kishan, A. U.
    Steinberg, M. L.
    Miccio, Joseph A.
    Camilleri, Philip
    Nagar, Himanshu
    BMC CANCER, 2023, 23 (01)
  • [17] A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)
    Sydney Wolfe
    Marshall A. Diven
    Ariel E. Marciscano
    Xi Kathy Zhou
    A. U. Kishan
    M. L. Steinberg
    Joseph A. Miccio
    Philip Camilleri
    Himanshu Nagar
    BMC Cancer, 23
  • [18] Stereotactic Ablative Fractionated Radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the Lung: A Randomized Phase II Trial
    Siva, S.
    Bressel, M.
    Kron, T.
    Mai, T.
    Le, H. V.
    Montgomery, R.
    Hardcastle, N.
    Rezo, A.
    Gill, S.
    Higgs, B. G.
    Pryor, D. I.
    Lourenco, R. De Abreu
    Awad, R.
    Chesson, B.
    Eade, T. N.
    Skala, M.
    Sasso, G.
    Wong, W.
    Vinod, S.
    Ball, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S3 - S4
  • [19] Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma
    McBride, Sean
    Sherman, Eric
    Tsai, C. Jillian
    Baxi, Shrujal
    Aghalar, Jahan
    Eng, Juliana
    Zhi, Wanqing Iris
    McFarland, Daniel
    Michel, Loren Scott
    Young, Robert
    Lefkowitz, Robert
    Spielsinger, Daniel
    Zhang, Zhigang
    Flynn, Jessica
    Dunn, Lara
    Ho, Alan
    Riaz, Nadeem
    Pfister, David
    Lee, Nancy
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (01) : 30 - +
  • [20] A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
    Tran, Phuoc T.
    Phillips, Ryan
    Shi, William
    Lim, Su Jin
    Antonarakis, Emmanuel S.
    Rowe, Steven P.
    Ross, Ashley
    Gorin, Michael A.
    Deville, Curtiland
    Greco, Stephen C.
    Paller, Channing Judith
    DeWeese, Theodore L.
    Song, Daniel Y.
    Wang, Hao
    Carducci, Michael Anthony
    Pienta, Kenneth J.
    Pomper, Martin
    Dicker, Adam P.
    Eisenberger, Mario A.
    Diehn, Maximilian
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
12345